Tokyo, May 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061618) titled 'Exploring the Impact of a Usage Monitoring System Integrated into Home Oxigen Therapy on Pulmonary Hypertension Management in Patients with Interstitial Lung Disease' on May 18.

Study Type: Observational

Primary Sponsor: Institute - Institute of Science Tokyo

Condition: Condition - Interstitial Lung Disease Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To evaluate the association between HOT adherence and the clinical course of pulmonary hypertension using objective assessments obtained from wearable devices, and to evaluate the utility of a web-based treatment monitoring system for preventive and therapeutic interventions in Group 3 pulmonary hypertension. Basic objectives2 - Efficacy

Eligibility: Age-lower limit - 20 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - Patients with interstitial lung disease who are receiving outpatient care at the Department of Respiratory Medicine, Institute of Science Tokyo (including the former Tokyo Medical and Dental University) Patients who have undergone or are scheduled to undergo echocardiographic examination Patients who will initiate use of a home oxygen monitoring tool during the study period, or patients already using a home oxygen monitoring tool but who have not previously received physician guidance based on monitoring data and will begin such guidance during the study period Key exclusion criteria - Patients diagnosed with pulmonary hypertension other than Group 3 (Groups 1, 2, 4, or 5) Patients strongly suspected of having pulmonary hypertension other than Group 3 (Groups 1, 2, 4, or 5) Patients who do not provide informed consent for participation in the study Patients judged by the attending physician to have a prognosis unlikely to allow completion of the study period Patients unable to attend regular outpatient visits Patients considered inappropriate for participation by the principal investigator or co-investigators Target Size - 20

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 04 Month 01 Day Anticipated trial start date - 2026 Year 06 Month 01 Day Last follow-up date - 2028 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070496

Disclaimer: Curated by HT Syndication.